Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity

Myocardial infarction (MI) is a leading cause of death worldwide. Reperfusion is considered as an optimal therapy following cardiac ischemia. However, the promotion of a rapid elevation of O(2) levels in ischemic cells produces high amounts of reactive oxygen species (ROS) leading to myocardial tiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodius, Sophie, de Klein, Niek, Jeanty, Céline, Sánchez-Iranzo, Héctor, Crespo, Isaac, Ibberson, Mark, Xenarios, Ioannis, Dittmar, Gunnar, Mercader, Nadia, Niclou, Simone P., Azuaje, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031222/
https://www.ncbi.nlm.nih.gov/pubmed/32076073
http://dx.doi.org/10.1038/s41598-020-59894-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031222/
https://www.ncbi.nlm.nih.gov/pubmed/32076073
http://dx.doi.org/10.1038/s41598-020-59894-4

Ejemplares similares